Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

An elevated level of serum uric acid (SUA) is associated with an increased risk of cardiovascular disease. Pharmacological intervention with urate-lowering agents, such as the conventional purine analogue xanthine oxidase (XO) inhibitor, allopurinol, has been used widely for a long period of time in clinical practice to reduce SUA levels.

Read more

Wyss-designed swabs enter human trials for COVID-19

Researchers at the Wyss Institute at Harvard University, in collaboration with health care, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.

Read more

“Frozen evolution” of an RNA virus suggests accidental release as a potential cause of arbovirus re-emergence

The mechanisms underlying virus emergence are rarely well understood, making the appearance of outbreaks largely unpredictable. Bluetongue virus serotype 8 (BTV-8), an arthropod-borne virus of ruminants, emerged in livestock in northern Europe in 2006, spreading to most European countries by 2009 and causing losses of billions of euros.

Read more

Coronavirus could help us reclaim city streets but only if officials act

As cities around the world close off select streets to through traffic during the pandemic, New York has lagged behind. Even though this is the densest city in the country and the area currently hardest hit by coronavirus in the world, Mayor Bill de Blasio has dragged his feet on giving New Yorkers breathing room by designating some streets car-free.

Read more

Effectiveness of the Common Elements Treatment Approach (CETA) in reducing intimate partner violence and hazardous alcohol use in Zambia (VATU): A randomized controlled trial

Both intimate partner violence (IPV) and alcohol misuse are highly prevalent, and partner alcohol misuse is a significant contributor to women’s risk for IPV.
There are few evidence-based interventions to address these problems in low- and middle-income countries (LMICs).

Read more
Copyright 2020 Ominy science

Content published here is for information purposes alone.